Success of Covid Antiviral Pills Hinges on Access to Speedy and Accurate Tests
By Editor - Mon Nov 22, 3:40 am
Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after. Now under federal review, both pills are being hailed by infectious-disease doctors not prone to superlatives. “This is truly a game changer,” said Dr. Daniel Griffin, an expert on infectious diseases and immunology at Columbia University.
Go here to read the rest: